Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve Pubget Overpricing |
lüll Sphingolipid mediators in cardiovascular cell biology and pathology Levade T; Auge N; Veldman RJ; Cuvillier O; Negre-Salvayre A; Salvayre RCirc Res 2001[Nov]; 89 (11): 957-68Sphingolipids have emerged as a new class of lipid mediators. In response to various extracellular stimuli, sphingolipid turnover can be stimulated in vascular cells and cardiac myocytes. Subsequent generation of sphingolipid molecules such as ceramide, sphingosine, and sphingosine-1-phosphate, is followed by regulation of ion fluxes and activation of various signaling pathways leading to smooth muscle cell proliferation, endothelial cell differentiation or apoptotic cell death, cell contraction, retraction, or migration. The importance of sphingolipids in cardiovascular signaling is illustrated by recent observations implicating them in physiological processes such as vasculogenesis as well as in frequent pathological conditions, including atherosclerosis and its complications.|Animals[MESH]|Apoptosis[MESH]|Cell Division[MESH]|Coronary Artery Disease/etiology[MESH]|Heart Diseases/*etiology[MESH]|Humans[MESH]|Ion Transport[MESH]|Myocardial Contraction[MESH]|Myocardial Reperfusion Injury/etiology[MESH]|Myocardium/cytology/*metabolism[MESH]|Neovascularization, Physiologic[MESH]|Radiation Injuries/etiology[MESH]|Signal Transduction[MESH]|Sphingolipids/chemistry/*physiology[MESH] |